Market Research Logo

Japan Pharmaceuticals & Healthcare Q1 2019

Japan Pharmaceuticals & Healthcare Q1 2019

Key View:

Japan will remain an attractive yet challenging market for multinational pharmaceutical firms. Medicine sales will bedriven by rising demand for healthcare services due to an ageing population and increased demand for chronic disease treatments.However, the government’s implementation of cost-containment measures and the growing use of generic medicines will limitopportunities for innovative drugmakers.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Asia Pacific Innovative Pharmaceuticals Risk/Reward Index
Japan Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Market Overview
Competitive Landscape
Company Profile
Astellas
AstraZeneca
Daiichi Sankyo
Eisai
GlaxoSmithKline
MSD
Mitsubishi Tanabe
Novartis
Pfizer
Sanofi
Sawai Pharmaceutical
Takeda Pharmaceutical Company
Japan Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report